Activin and Inhibin

GS-626510 is a potent, and orally active BET family bromodomains inhibitor, with K d values of 0.59-3.2 nM for BRD2/3/4, with IC 50 values of 83 nM and 78 nM foe BD1 and BD2 , respectivelyForm:SolidIC50&amp: Target:BRD2 0.59-2.5 nM (Kd) BRD3

GS-626510 is a potent, and orally active BET family bromodomains inhibitor, with K d values of 0.59-3.2 nM for BRD2/3/4, with IC 50 values of 83 nM and 78 nM foe BD1 and BD2 , respectivelyForm:SolidIC50&amp: Target:BRD2 0.59-2.5 nM (Kd) BRD3

GS-626510 is a potent, and orally active BET family bromodomains inhibitor, with K d values of 0.59-3.2 nM for BRD2/3/4, with IC 50 values of 83 nM and 78 nM foe BD1 and BD2 , respectivelyForm:SolidIC50&amp: Target:BRD2 0.59-2.5 nM (Kd) BRD3

GS-626510 is a potent, and orally active BET family bromodomains inhibitor, with K d values of 0.59-3.2 nM for BRD2/3/4, with IC 50 values of 83 nM and 78 nM foe BD1 and BD2 , respectivelyIC50&amp: Target:BRD2 0.59-2.5 nM (Kd) BRD3 0.65-0.66 nM (Kd)

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine specific demethylase 1 (LSD1) , with a K d value of 9 nM and a biochemical IC 50 of 37 nM.Appearance:SolidIC50&amp: Target:IC50: 37 nM (LSD1), Kd: 8 nM (LSD1) .In Vitro:GSK690 (1-10 μM)

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine specific demethylase 1 (LSD1) , with a K d value of 9 nM and a biochemical IC 50 of 37 nM.Appearance:SolidIC50&amp: Target:IC50: 37 nM (LSD1), Kd: 8 nM (LSD1) .In Vitro:GSK690 (1-10 μM)

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine specific demethylase 1 (LSD1) , with a K d value of 9 nM and a biochemical IC 50 of 37 nM.Appearance:SolidIC50&amp: Target:IC50: 37 nM (LSD1), Kd: 8 nM (LSD1) .In Vitro:GSK690 (1-10 μM)

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine specific demethylase 1 (LSD1) , with a K d value of 9 nM and a biochemical IC 50 of 37 nM.Appearance:SolidIC50&amp: Target:IC50: 37 nM (LSD1), Kd: 8 nM (LSD1) .In Vitro:GSK690 (1-10 μM)

GSK 690 (Hydrochloride) is a reversible inhibitor of lysine specific demethylase 1 (LSD1) , with a K d value of 9 nM and a biochemical IC 50 of 37 nM.IC50&amp: Target:IC50: 37 nM (LSD1), Kd: 8 nM (LSD1) .In Vitro:GSK690 (1-10 μM) acts together with

GSK-269984A is a Prostaglandin E2 Receptor 1 (EP1) antagonist with a pIC 50 of 7.9.In VitroResults from [ 3 H]-PGE 2 binding assay in CHO cells overexpressing the human EP 1 receptor demonstrate that GSK-269984A is an antagonist of EP 1 receptor

GSK-269984A is a Prostaglandin E2 Receptor 1 (EP1) antagonist with a pIC 50 of 7.9.In VitroResults from [ 3 H]-PGE 2 binding assay in CHO cells overexpressing the human EP 1 receptor demonstrate that GSK-269984A is an antagonist of EP 1 receptor

GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C ( CTSC ). GSK-2793660 can be used for the research of bronchiectasis.Appearance:SolidIC50&amp: Target:Cathepsin C (CTSC)In Vivo:GSK-2793660 is a cathepsin C (also known as